APT
AstraZeneca acquires biotech’s unique antithrombotic drug
January 5, 2017Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition
AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
